Recent Events & Catalysts
BeOne Medicines AG (ONC) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
Recursion Pharmaceuticals: I'm Still Bearish Despite Recent Genentech News
SeekingAlpha · 1d ago
BeOne Medicines And Revolution Medicines Form Clinical Collaboration To Evaluate Drug Combinations Using Select Clinical-Stage Oncology Assets From BeOne With Any Of Revolution’s Four Clinical RAS(ON)
Benzinga · 1d ago
TD Cowen Maintains Buy on BeOne Medicines, Raises Price Target to $454
Benzinga · 5d ago
RBC Capital Maintains Outperform on BeOne Medicines, Lowers Price Target to $450
Benzinga · 5d ago
Truist Securities Maintains Buy on BeOne Medicines, Raises Price Target to $418
Benzinga · 5d ago
Aaron Rosenberg Implements A Sell Strategy: Offloads $361K In BeOne Medicines Stock
Benzinga · 5d ago
Guggenheim Maintains Buy on BeOne Medicines, Raises Price Target to $430
Benzinga · 5d ago
Citizens Maintains Market Outperform on BeOne Medicines, Raises Price Target to $405
Benzinga · 5d ago
SEC Filings (90 days)
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-08-05 · 6d ago · Material
Other events
Filed 2026-06-26 · 46d ago
Departure/appointment of directors or officers, Submission of matters to a vote of security holders, Financial statements and exhibits
Filed 2026-06-11 · 61d ago
Other events, Financial statements and exhibits
Filed 2026-05-15 · 88d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.